Use of stem cells in heart failure treatment: where we stand and where we are going

Review

Abstract: End-stage heart failure is the final common pathway of an irreversible process associated with loss

Palabras claves:

bone marrow-derived cell therapy, cardiac stem cell therapy, dilated cardiomyopathy, Heart Failure

Autores:

Andrea M. Cordero-Reyes, García-Rivas G., Guerrero-Beltrán C.E.n., Sánchez L.A., Torre-Amione G.

Fuentes:

scopus